BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26810540)

  • 21. Functional movement disorders are not uncommon in the elderly.
    Batla A; Stamelou M; Edwards MJ; Pareés I; Saifee TA; Fox Z; Bhatia KP
    Mov Disord; 2013 Apr; 28(4):540-3. PubMed ID: 23418043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial comorbidities and obesity are associated with lower urinary tract symptoms in children with voiding dysfunction.
    Oliver JL; Campigotto MJ; Coplen DE; Traxel EJ; Austin PF
    J Urol; 2013 Oct; 190(4 Suppl):1511-5. PubMed ID: 23429069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urodynamic Findings and Renal Function in Children with Neurogenic Bladder after Myelomeningocele.
    Korzeniecka-Kozerska A; Porowski T; Bagińska J; Wasilewska A
    Urol Int; 2015; 95(2):146-52. PubMed ID: 26067248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between lower urinary tract dysfunction and glycemic control in women with type 2 diabetes: A cross-sectional study.
    Tai HC; Tai TY; Yang WS; Wang SW; Yu HJ
    J Diabetes Complications; 2016 Apr; 30(3):415-9. PubMed ID: 26861946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder-bowel interactions: Do we understand pelvic organ cross-sensitization? International Consultation on Incontinence Research Society (ICI-RS) 2018.
    Panicker JN; Marcelissen T; von Gontard A; Vrijens D; Abrams P; Wyndaele M
    Neurourol Urodyn; 2019 Dec; 38 Suppl 5():S25-S34. PubMed ID: 31821639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
    Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M
    Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is type-2 diabetes mellitus associated with overactive bladder symptoms in men with lower urinary tract symptoms?
    Bang WJ; Lee JY; Koo KC; Hah YS; Lee DH; Cho KS
    Urology; 2014 Sep; 84(3):670-4. PubMed ID: 25168549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms.
    Sacco E; D'Addessi A; Racioppi M; Pinto F; Totaro A; Bassi P
    Int J Gynaecol Obstet; 2012 May; 117(2):168-72. PubMed ID: 22361478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
    de Carvalho FL; Gomes CM; Apostolos-Pereira SL; Bessa J; Pinheiro M; Marchiori PE; Bruschini H; Srougi M; Callegaro D
    Neurourol Urodyn; 2016 Jan; 35(1):39-43. PubMed ID: 25212666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes might adversely affect expression and function of interstitial cells in the urinary bladder and urethra in humans: a new mechanism in the development of diabetic lower urinary dysfunction?
    Canda AE
    Med Hypotheses; 2011 May; 76(5):632-4. PubMed ID: 21288651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome associated with reduced lower urinary tract symptoms in middle-aged men receiving health checkup.
    Yang TK; Hsieh JT; Chen SC; Chang HC; Yang HJ; Huang KH
    Urology; 2012 Nov; 80(5):1093-7. PubMed ID: 23107400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms.
    Chapple CR; Drake MJ; Van Kerrebroeck P; Cardozo L; Drogendijk T; Klaver M; Van Charldorp K; Hakimi Z; Compion G
    BJU Int; 2014 May; 113(5):696-703. PubMed ID: 24712917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society.
    Austin PF; Bauer SB; Bower W; Chase J; Franco I; Hoebeke P; Rittig S; Walle JV; von Gontard A; Wright A; Yang SS; Nevéus T
    Neurourol Urodyn; 2016 Apr; 35(4):471-81. PubMed ID: 25772695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes.
    Sacco E; Tienforti D; Bientinesi R; D'Addessi A; Racioppi M; Pinto F; Totaro A; Vittori M; D'Agostino D; Bassi P
    Neurourol Urodyn; 2014 Jan; 33(1):142-6. PubMed ID: 23868794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower urinary tract pathology evaluation in Nigeria: practice and limitations at a private urology centre.
    Akporiaye LE; Aisuodionoe-Shadrach OI
    West Afr J Med; 2013; 32(3):216-9. PubMed ID: 24122689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
    Sand PK; Sand RI
    Dis Mon; 2013 Jul; 59(7):261-8. PubMed ID: 23786660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower urinary tract functions in a series of Charcot-Marie-Tooth neuropathy patients.
    Krhut J; Mazanec R; Seeman P; Mann-Gow T; Zvara P
    Acta Neurol Scand; 2014 May; 129(5):319-24. PubMed ID: 23937377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy.
    Andrade R; Tanajura D; Santana D; Santos Dd; Carvalho EM
    Int Braz J Urol; 2013; 39(6):861-6. PubMed ID: 24456778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.